IntelGenx seeks to extend 8% convertible debentures by two years, cut conversion price

By Rebecca Melvin

New York, May 12 – IntelGenx Technologies Corp. said it proposing to amend the terms of its 8% convertible unsecured subordinated debentures due June 30, 2020.

Specifically, it seeks to extend the maturity date of the C$7,577,000 of debentures outstanding to June 30, 2022 and to cut the conversion price to C$0.50 from C$1.35.

The debentures were issued in 2017 on July 12 and Aug. 8.

IntelGenx is a Quebec-based drug delivery company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.